PhD Monitor
/Detail
Cancer Research and Immunology● OpenPreview

PhD Position in Antigen-RNA Complexes and Cancer Vaccination

Investigate novel antigen-RNA vaccine platforms to overcome immune tolerance in cancer therapy.

Best for:Best for life sciences graduates with a Master's degree and hands-on laboratory experience in immunology or molecular biology.

INSERM · Nice, France · R1 · First-stage researcher
More professors at INSERM
Cancer VaccinationImmunologyRNA BiologyTumor ModelsInnate Immunity
Deadline
Nov 15, 2026
26 days
Funding
Salaried
3 years
Start date
2027-01-01
Fixed-term
Location
Nice
France

Overview

A 3-year doctoral contract is available at the Institute for Research on Cancer and Aging of Nice (IRCAN), hosted within the University Hospital Institute RespirERA and supported by the France 2030 programme. The research focuses on characterising the cellular and molecular determinants of immunogenicity for antigen-RNA complexes to improve therapeutic cancer vaccination. The successful candidate will employ techniques ranging from cell culture and flow cytometry to preclinical tumour models and immune monitoring. Applicants are expected to work with rigour, autonomy, and strong collaboration skills within an interdisciplinary team.

PhDCancer ResearchImmunologyRNAVaccinationINSERMIRCAN

What you'll do

  • Characterise cellular and molecular determinants of immunogenicity for antigen-RNA complexes.
  • Investigate innate sensors and responsive cell types involved in nucleic acid sensing pathways.
  • Evaluate antigen presentation and therapeutic efficacy using preclinical tumour models.
  • Perform immune monitoring, flow cytometry, and cellular assays.
  • Conduct in vitro RNA and protein biochemistry experiments.

Requirements

Degree required: Master’s degree (M2 or equivalent) in life sciences, cell or molecular biology, immunology, or cancer biology

Degree offered: PhD

Language: Good command of English

Instruction: English

Required skills
  • Hands-on laboratory experience in life sciences
  • Rigour, autonomy, critical thinking, and team spirit
  • Good command of English
Nice to have
Practical skills in cell culture, RT-qPCR, and protein analysisPrior experience in immunology or RNA biologyExperience with imaging or flow cytometryBackground in RNA and protein biochemistry
Eligibility
  • Applicants must hold an M2 degree or equivalent in a relevant life sciences discipline.

Funding & terms

Type
Salaried
Amount
—
Duration
3 years
Programme
France 2030 – IHU RespirERA (ANR-23-IHU-0007)
French National Research Agency (ANR)

How to apply

Deadline: 2026-11-15 (Europe/Paris)

Interested candidates should submit a CV, a cover letter, M1 and M2 academic transcripts, and the contact details of two referees via email. Ensure the email subject line reads exactly: “PhD application – Position – Antigen–RNA complexes and cancer vaccination”.

Documents required
  • CV
  • Cover letter
  • M1/M2 academic transcripts
  • 2 reference letters
✉Apply by email

Contact

PB
Prof.
Patrick Brest
IRCAN – Équipe Patrick Brest
Lab
IRCAN – Team Patrick Brest
INSERM
France 2030 – IHU RespirERA (ANR-23-IHU-0007)France
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
26 days until the deadline — open this position on its website.